Metronidazole Appears Not to Be a Human Teratogen: Review of Literature
1997

Metronidazole and Pregnancy: Is It Safe?

Sample size: 5333 publication Evidence: moderate

Author Information

Author(s): Barbara J. Struthers

Primary Institution: G.D. Searle & Co.

Hypothesis

Is metronidazole teratogenic when used during pregnancy?

Conclusion

Metronidazole does not appear to be associated with an increased risk of congenital anomalies in infants born to mothers who used it during pregnancy.

Supporting Evidence

  • Studies show no significant increase in congenital anomalies among infants born to mothers treated with metronidazole.
  • Metronidazole treatment may reduce the incidence of preterm birth and low birth weight.
  • Controlled studies indicate that the risk of defects is similar to that of the general population.

Takeaway

Doctors can use metronidazole to treat infections in pregnant women without worrying about causing birth defects.

Methodology

Review of nearly four decades of literature on metronidazole use in pregnant women.

Potential Biases

Potential bias due to reliance on published reports and lack of detailed medical records.

Limitations

No controlled clinical trials specifically designed to determine teratogenicity in humans.

Participant Demographics

Pregnant women treated with metronidazole for various infections.

Statistical Information

P-Value

0.006

Confidence Interval

0.9-1.6

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication